Dimitrios N. Vatakis, Ph.D. - Publications

Affiliations: 
2003 University of Southern California, Los Angeles, CA, United States 
Area:
Immunology

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Saleh S, Lu HK, Evans V, Harisson D, Zhou J, Jaworowski A, Sallmann G, Cheong KY, Mota TM, Tennakoon S, Angelovich TA, Anderson J, Harman A, Cunningham A, Gray L, ... ... Vatakis DN, et al. HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB. Retrovirology. 13: 49. PMID 27459960 DOI: 10.1186/s12977-016-0284-7  0.6
2015 Kim SG, Lowe EL, Dixit D, Seyeon Youn C, Kim IJ, Jung JB, Rovner R, Zack JA, Vatakis DN. Cocaine-mediated impact on HIV infection in humanized BLT mice. Scientific Reports. 5: 10010. PMID 26084721 DOI: 10.1038/srep10010  0.6
2015 Burke BP, Levin BR, Zhang J, Sahakyan A, Boyer J, Carroll MV, Colón JC, Keech N, Rezek V, Bristol G, Eggers E, Cortado R, Boyd MP, Impey H, Shimizu S, ... ... Vatakis DN, et al. Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector. Molecular Therapy. Nucleic Acids. 4: e236. PMID 25872029 DOI: 10.1038/mtna.2015.10  0.6
2015 McCracken MN, Vatakis DN, Dixit D, McLaughlin J, Zack JA, Witte ON. Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging. The Journal of Clinical Investigation. 125: 1815-26. PMID 25822024 DOI: 10.1172/JCI77326  0.6
2013 Nixon CC, Vatakis DN, Reichelderfer SN, Dixit D, Kim SG, Uittenbogaart CH, Zack JA. HIV-1 infection of hematopoietic progenitor cells in vivo in humanized mice. Blood. 122: 2195-204. PMID 23886835 DOI: 10.1182/blood-2013-04-496950  0.6
2012 Vatakis DN, Bristol GC, Kim SG, Levin B, Liu W, Radu CG, Kitchen SG, Zack JA. Using the BLT humanized mouse as a stem cell based gene therapy tumor model. Journal of Visualized Experiments : Jove. e4181. PMID 23271478 DOI: 10.3791/4181  0.6
2011 Vatakis DN, Koya RC, Nixon CC, Wei L, Kim SG, Avancena P, Bristol G, Baltimore D, Kohn DB, Ribas A, Radu CG, Galic Z, Zack JA. Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 108: E1408-16. PMID 22123951 DOI: 10.1073/pnas.1115050108  0.6
2011 Marban C, Su T, Ferrari R, Li B, Vatakis D, Pellegrini M, Zack JA, Rohr O, Kurdistani SK. Genome-wide binding map of the HIV-1 Tat protein to the human genome. Plos One. 6: e26894. PMID 22073215 DOI: 10.1371/journal.pone.0026894  0.6
2011 Vatakis D, McMillan M. The signal peptide sequence impacts the immune response elicited by a DNA epitope vaccine. Clinical and Vaccine Immunology : Cvi. 18: 1776-80. PMID 21832097 DOI: 10.1128/CVI.05179-11  0.6
2009 Vatakis DN, Kim S, Kim N, Chow SA, Zack JA. Human immunodeficiency virus integration efficiency and site selection in quiescent CD4+ T cells. Journal of Virology. 83: 6222-33. PMID 19369341 DOI: 10.1128/JVI.00356-09  0.6
2007 Burke B, Brown HJ, Marsden MD, Bristol G, Vatakis DN, Zack JA. Primary cell model for activation-inducible human immunodeficiency virus. Journal of Virology. 81: 7424-34. PMID 17475639 DOI: 10.1128/JVI.02838-06  0.6
2007 Vatakis DN, Bristol G, Wilkinson TA, Chow SA, Zack JA. Immediate activation fails to rescue efficient human immunodeficiency virus replication in quiescent CD4+ T cells. Journal of Virology. 81: 3574-82. PMID 17229711 DOI: 10.1128/JVI.02569-06  0.6
2006 Arlen PA, Brooks DG, Gao LY, Vatakis D, Brown HJ, Zack JA. Rapid expression of human immunodeficiency virus following activation of latently infected cells. Journal of Virology. 80: 1599-603. PMID 16415036 DOI: 10.1128/JVI.80.3.1599-1603.2006  0.6
2005 Vatakis DN, Koh YT, McMillan M. CD4+ T cell epitope affinity to MHC II influences the magnitude of CTL responses elicited by DNA epitope vaccines. Vaccine. 23: 2639-46. PMID 15780447 DOI: 10.1016/j.vaccine.2004.10.039  0.6
Show low-probability matches.